Venetoclax and Azacitidine in the Treatment of NPM1-Mutated Donor Cell-Derived Leukemia in a Patient With Fanconi Anemia: Case Report and Literature Review

JCO Precis Oncol. 2023 Jun:7:e2200693. doi: 10.1200/PO.22.00693.
No abstract available

Publication types

  • Review
  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azacitidine / therapeutic use
  • Fanconi Anemia*
  • Humans
  • Leukemia*
  • Nuclear Proteins / genetics

Substances

  • venetoclax
  • Azacitidine
  • Nuclear Proteins